IP Library › Granted Patent US 11,254,729
Granted Patent B2
US 11,254,729 · App. 17/166,441 · Granted Feb 22, 2022

IL-7R-α binding compounds

Inventors: William J. Dower (Menlo Park, CA); Michael C. Needels (Menlo Park, CA); Ronald W. Barrett (Menlo Park, CA); Alice V. Bakker (Menlo Park, CA); Steven E. Cwirla (Menlo Park, CA)
Assignee: MEDIKINE, INC.
C07K14/7155C07K2319/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,254,729
App. No.
17/166,441
Granted
Feb 22, 2022
Kind
B2
Abstract

IL-7Rα ligands and compounds comprising IL-7Rα ligands are disclosed. The IL-7Rα binding compounds include fusion proteins comprising the IL-7Rα ligands and can act as IL-7R agonists.

Claims (11)

1. An IL-7Rα ligand, wherein,

the IL-7Rα ligand binds to the human IL-7Rα subunit with an IC 50 of less than 100 μM; and

the IL-7Rα ligand consists of an amino acid sequence selected from any one of SEQ ID NOS: 402, 407, 582, and 655.

2. The IL-7Rα ligand of claim 1 , wherein the IL-7Rα ligand consists of the amino acid sequence of SEQ ID NO: 402.

3. The IL-7Rα ligand of claim 1 , wherein the IL-7Rα ligand consists of the amino acid sequence of SEQ ID NO: 407.

4. The IL-7Rα ligand of claim 1 , wherein the IL-7Rα ligand consists of the amino acid sequence of SEQ ID NO: 582.

5. The IL-7Rα ligand of claim 1 , wherein the IL-7Rα ligand consists of the amino acid sequence of SEQ ID NO: 655.

6. A compound comprising at least one IL-7Rα ligand of claim 1 .

7. The compound of claim 6 , wherein the compound is selected from a peptide, a conjugate, and a fusion protein.

8. A pharmaceutical composition comprising the IL-7Rα ligand of claim 1 .

9. A pharmaceutical composition comprising the compound of claim 6 .

Assignments (2)
SECURITY INTEREST Recorded Oct 20, 2023
From: MEDIKINE, INC.
To: SAMSARA BIOCAPITAL, L.P.; LIGHTSPEED GENERAL PARTNER XIV-B (IGNITE), L.P.; BLUEBIRD VENTURES I, L.P.; JEFFREY W. AND CHRISTINA R. BIRD TRUST U/A/D; MCMEEKIN, DERMOT; WS INVESTMENT COMPANY, LLC (23A)
Reel/Frame 065303/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2021
From: DOWER, WILLIAM J.; NEEDELS, MICHAEL C.; BARRETT, RONALD W.; BAKKER, ALICE V.; CWIRLA, STEVEN E.
To: MEDIKINE, INC.
Reel/Frame 055374/0870 →
Continuity (2)
Provisional Application 62969432 · Feb 3, 2020
Related Publication 20210253669A1 · Aug 19, 2021